Causal insights from failure. What pharmacovigilance can teach us about causality

It is the business of pharmacovigilance to evidence causal failure: when the effects of the drugs are unexpected. Simply knowing that a medicine can affect or interact with a particular biological mechanism is itself a valuable piece of causal information, argue Elena Rocca, Rani Lill Anjum and Stephen Mumford in a recent publication. Read more about this and the CauseHealth collaboration with Uppsala Monitoring Centre (UMC) in Uppsala Reports.

Author: CauseHealth

CauseHealth - Causation, Complexity and Evidence in Health Sciences

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: